Form 4 for ALT Altimmune, Inc.
Accepted 2025-02-03 00:00:00 ET · period of report 2025-01-30 · accession 0001104659-25-008772 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-03 | 2025-01-30+ | ALT | Harris Matthew Scott | Chief Medical Off | F - Tax | $6.78 | -7,990 | 76.8K | -9% | -$54.2K |
| DM | 2025-02-03 | 2025-01-30+ | ALT | Harris Matthew Scott | Chief Medical Off | M - OptEx | $0.00 | +23.2K | 78.9K | +42% | $0 |
| D | 2025-02-03 | 2025-01-31 | ALT | Harris Matthew Scott | Chief Medical Off | A - Grant | $5.18 | +1,905 | 72.7K | +3% | +$9,868 |
| DM | 2025-02-03 | 2025-01-30+ | ALT | Harris Matthew Scott | Chief Medical Off | M - OptEx | $0.00 | +23.2K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 | 2025-02-02 | F | D | 2,708 | $6.64 | 81,856 | D | — | — | |
| 2 | Common | Common Stock, par value $0.0001 | 2025-01-30 | M | A | 9,275 | $0.00 | 74,000 | D | — | — | (F2) Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. |
| 3 | Common | Common Stock, par value $0.0001 | 2025-01-30 | F | D | 3,173 | $7.00 | 70,827 | D | — | — | |
| 4 | Common | Common Stock, par value $0.0001 | 2025-02-02 | M | A | 7,775 | $0.00 | 84,564 | D | — | — | (F2) Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. |
| 5 | Common | Common Stock, par value $0.0001 | 2025-02-01 | M | A | 6,166 | $0.00 | 78,898 | D | — | — | (F2) Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. |
| 6 | Common | Common Stock, par value $0.0001 | 2025-02-01 | F | D | 2,109 | $6.64 | 76,789 | D | — | — | |
| 7 | Common | Common Stock, par value $0.0001 | 2025-01-31 | A | A | 1,905 | $5.18 | 72,732 | D | — | — | (F4) In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 1, 2024. |
| 8 | Derivative | Restricted Stock Units | 2025-01-30 | M | A | 9,275 | $0.00 | 18,550 | D | — · — to — | 9,275 Common Stock, par value $0.0001 | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. (F5) The RSUs vest in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. |
| 9 | Derivative | Restricted Stock Units | 2025-02-02 | M | A | 7,775 | $0.00 | 7,775 | D | — · — to — | 7,775 Common Stock, par value $0.0001 | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. (F7) The RSUs vest in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. |
| 10 | Derivative | Restricted Stock Units | 2025-02-01 | M | A | 6,166 | $0.00 | 0 | D | — · — to — | 6,166 Common Stock, par value $0.0001 | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. (F6) The RSUs vest in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. |